HomeIOVA • NASDAQ
add
Iovance Biotherapeutics Inc
Previous close
$3.83
Day range
$3.50 - $3.84
Year range
$1.64 - $5.64
Market cap
1.56B USD
Avg Volume
14.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Q4 earnings report for Iovance Biotherapeutics
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 86.77M | 17.74% |
Operating expense | 117.12M | 2.09% |
Net income | -71.90M | 8.47% |
Net profit margin | -82.87 | 22.26% |
Earnings per share | -0.18 | 30.77% |
EBITDA | -63.53M | 18.61% |
Effective tax rate | -0.26% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 296.98M | -8.28% |
Total assets | 913.17M | 0.30% |
Total liabilities | 214.59M | 7.28% |
Total equity | 698.58M | — |
Shares outstanding | 411.96M | — |
Price to book | 2.25 | — |
Return on assets | -20.20% | — |
Return on capital | -24.44% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -71.90M | 8.47% |
Cash from operations | -52.56M | 28.28% |
Cash from investing | 775.00K | -96.73% |
Cash from financing | 56.17M | 2,332.74% |
Net change in cash | 4.96M | 110.23% |
Free cash flow | -94.96M | -111.86% |
About
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Founded
2007
Headquarters
Website
Employees
975
